Results 23,101-23,120 of 33,581 for speaker:Catherine Connolly

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: In being.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: What is the breakdown of the laboratories? I want to be clear about the laboratories. One is American but operates in Ireland. Is that correct?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: Is that Quest Diagnostics in half of these 31 cases?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: Is MedLab the one with the operation in Ireland?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: The HSE is also being sued. In all of the letters then, is it either one or both of these labs plus the HSE that is being sued?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: Is it correct that the HSE has adopted a new approach and that a paper will be sent in to the committee to clarify that?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: Yes, I do. Is Mr. Breen at liberty to tell us where the State Claims Agency stands with these cases in the context of hat new process?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: The State Claims Agency is, in effect, acting as an agent for the laboratories.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: The agency will rely on its indemnities.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: There are contracts with these laboratories. What contracts are in place in terms of time?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: What about Quest Diagnostics?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: The witnesses can come back with the precise date. Will the contract with Quest be up this year?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: That is this year.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: What about MedLab Pathology?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: What are the plans for those contracts?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: The new system being put in place will determine the type of lab to be sought.

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: Will it be outside the country? Have the witnesses assessed the capacity within the country for the new system?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: When will that assessment be ready?

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: It is an extremely important question in terms of value for money. I sat on the health forum years ago and watched this debacle emerge when all the experts told us not to outsource. Quest was mentioned in particular at the time. I am not blaming the witnesses for that but I certainly put blame on the establishment of the time and the type of philosophy that existed. We watched this happen...

Public Accounts Committee: Implications of CervicalCheck Revelations (Resumed) (14 Jun 2018)

Catherine Connolly: There is no clinical lead.